The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

1 recalls tagged with this hazard.

Results

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning2023-03-16

Biohaven Pharmaceuticals Inc., of New Haven, Conn.Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister packThe recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.